Old school regimen may turn the tide in metastatic breast cancer
Gezgen, G.; Roach, E.C.; Kizilarslanoglu, M.C.; Altundag, K.
Journal of BUON Official Journal of the Balkan Union of Oncology 16(4): 781
2011
ISSN/ISBN: 1107-0625 PMID: 22331741 Document Number: 654394
Document emailed within 1 workday
Related Documents
Barker, P. 1998: It's time to turn the tide Nursing Times 94(46): 70-72Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Gebauer, G.; Jäger, W.; Lang, N. 1998: mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells Anticancer Research 18(2a): 1191-1195
Koca, D.; Ozdemir, O.; Demir, D.; Akdeniz, H.; Kurt, M. 2015: Second-Line Modified FOLFOX6 Regimen in the Patients with Metastatic Esophagus Cancer Hepato-Gastroenterology 62(140): 902-906
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Piot, P. 2000: Global AIDS epidemic: time to turn the tide : AIDS research in Africa Science (Washington, D.C.) 288(5474): 2176-2178
Goosby, E.; Dybul, M.; Fauci, A.S.; Fauci, A.A.; Fu, J.; Walsh, T.; Needle, R.; Bouey, P. 2012: The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic Journal of Acquired Immune Deficiency Syndromes 60 Suppl. 3: S51-S56
Durai, R.; Ruhomauly, S.N.; Wilson, E.; Hoque, H. 2009: Metastatic renal cell carcinoma presenting as a breast lump in a treated breast cancer patient Singapore Medical Journal 50(8): e277-e279
Yokdang, N.; Buxton, N.D.; Buxton, I.L.O. 2009: Measurement of human breast tumor cell-secreted shNDPK-B in a murine breast cancer model suggests its role in metastatic progression Proceedings of the Western Pharmacology Society 52: 88-91
Xiao Kuan, Y.A.N.G.; Hua Guo, Z.H.O.U. 2004: CORSIM-based simulation approach to evaluation of direct left turn versus right turn plus U-turn from driveways Journal of Transportation Engineering 130(1): 68-75
Fornasiero, A.; Daniele, O.; Aversa, S.M.; Ghiotto, C.; Morandi, P.; Fiorentino, M.V. 1987: A 5-day regimen of cyclophosphamide, adriamycin, platinum (CAP) in refractory breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(4): 310-312
Bramwell, V.H.; Howell, A.; Scarffe, H.; Crowther, D.; Sellwood, R.A. 1982: VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer Cancer Treatment Reports 66(11): 1999-2000
de Graaf, H.; Willemse, P.H.; Sleijfer, D.T.; de Vries, E.G.; Van der Graaf, W.T.; Beukema, J.; Mulder, N.H. 1994: Effective conditioning regimen for premenopausal patients with advanced breast cancer Anticancer Research 14(6b): 2799-2804
Matsutani, S.; Tanaka, H.; Sakurai, K.; Lee, T.; Toyokawa, T.; Kubo, N.; Muguruma, K.; Kimura, K.; Nagahara, H.; Noda, E.; Amano, R.; Maeda, K.; Sawada, T.; Ohira, M.; Hirakawa, K. 2013: A case of metastatic gastric cancer from breast cancer treated with proximal gastrectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2210-2213
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Nicholson, B.; Paul, D.; Shyr, Y.; Garrett, M.; Hande, K.R.; Johnson, D.H. 1997: Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase Ii trial Seminars in Oncology 24(4 Suppl 11: S11
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Honda, S.; Toi, M.; Shimizu, S.; Hayashi, K.; Tominaga, T. 1997: The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(6): 679-683